.jpg)
.png)
The US Food and Drug Administration (FDA) has approved the B-cell depleting agent inebilizumab-cdon (Uplizna, Amgen) for the treatment of immunoglobulin G4-related disease (IgG4-RD). This is the first and only treatment approved for this rare autoimmune disease in the United States. An estimated 200,000 people in the United States are living with IgG4-RD...
???? Are You a Music Artist Ready to Be Heard? ????
It’s time to stop playing around and get your music on real radio. Join a platform that truly supports artists and gives you the exposure you deserve.
SugarWaterRadio is changing the game—one song at a time.
Get real airplay, real listeners, and real results.
???? Submit your music now at SugarWaterRadio.com
Let’s make your dream a reality.
CLICK HERE & TURN UP YOUR FUTURE! ????
Copyright © 2023 swsports. All Rights Reserved
